Prevention of graft-versus-host disease (GVHD) by elimination of recipient-reactive donor T cells with recombinant toxins that target the interleukin 2 (IL-2) receptor.

Harris, D T

Prevention of graft-versus-host disease (GVHD) by elimination of recipient-reactive donor T cells with recombinant toxins that target the interleukin 2 (IL-2) receptor. [electronic resource] - Bone marrow transplantation Jan 1999 - 137-44 p. digital

Publication Type: Journal Article

0268-3369

10.1038/sj.bmt.1701535 doi


ADP Ribose Transferases
Animals
Bacterial Toxins--pharmacology
Bone Marrow Transplantation--immunology
Cell Count
Exotoxins--pharmacology
Female
Graft vs Host Disease--prevention & control
Humans
Isoantibodies--immunology
Mice
Phenotype
Pregnancy
Pseudomonas aeruginosa
Receptors, Interleukin-2--drug effects
Recombinant Proteins--pharmacology
Stem Cells--physiology
T-Lymphocytes--drug effects
Tissue Donors
Virulence Factors
Pseudomonas aeruginosa Exotoxin A